Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rubin

Showing results (661-670 of 717) with videos related to

Pageof 72
Sort By:
Cancer Research|September 19, 2007
Deletion of the AU-rich RNA binding protein Apobec-1 reduces intestinal tumor burden in Apc(min) miceValerie Blanc, Jeffrey O Henderson, Rodney D Newberry, et al.
Radiologic Clinics of North America|August 16, 2000
Society of Breast Imaging residency and fellowship training curriculumS A Feig, F M Hall, D M Ikeda, et al.
The Journal of Nutrition|October 30, 2004
Inhibition of Hedgehog signaling protects adult mice from diet-induced weight gainKimberly K Buhman, Li Chun Wang, Yuzhu Tang, et al.
Scientific Reports|December 8, 2025
Liver injury in a preclinical model of short bowel syndrome is associated with impaired autophagyDaniel M Alligood, Alex Park, Kerry Swanson, et al.
The New England Journal of Medicine|November 7, 1996
Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1S C Rubin, I Benjamin, K Behbakht, et al.
The American Journal of Clinical Nutrition|March 29, 2013
Gastric cancer in Zambian adults: a prospective case-control study that assessed dietary intake and antioxidant status by using urinary isoprostane excretionAkwi W Asombang, Violet Kayamba, Mpala Mwanza-Lisulo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Impact of raloxifene or tamoxifen use on endometrial cancer risk: a population-based case-control studyAngela DeMichele, Andrea B Troxel, Jesse A Berlin, et al.
Environmental Health Perspectives|June 15, 2000
Workshop to identify critical windows of exposure for children's health: reproductive health in children and adolescents work group summaryG K Lemasters, S D Perreault, B F Hales, et al.
Cancer Biology & Therapy|July 26, 2011
Tissue-based immune monitoring I: tumor core needle biopsies allow in-depth interrogation of the tumor microenvironmentAndrea R Hagemann, Mark Cadungog, Ian S Hagemann, et al.
Gynecologic Oncology|March 31, 2015
A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation - An NRG Oncology/Gynecologic Oncology Group studyRobert L Coleman, Michael W Sill, Katherine Bell-McGuinn, et al.
Pageof 72

Showing results (661-670 of 717) with videos related to

Sort By:
Pageof 72
Cancer Research|September 19, 2007
Deletion of the AU-rich RNA binding protein Apobec-1 reduces intestinal tumor burden in Apc(min) miceValerie Blanc, Jeffrey O Henderson, Rodney D Newberry, et al.
Radiologic Clinics of North America|August 16, 2000
Society of Breast Imaging residency and fellowship training curriculumS A Feig, F M Hall, D M Ikeda, et al.
The Journal of Nutrition|October 30, 2004
Inhibition of Hedgehog signaling protects adult mice from diet-induced weight gainKimberly K Buhman, Li Chun Wang, Yuzhu Tang, et al.
Scientific Reports|December 8, 2025
Liver injury in a preclinical model of short bowel syndrome is associated with impaired autophagyDaniel M Alligood, Alex Park, Kerry Swanson, et al.
The New England Journal of Medicine|November 7, 1996
Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1S C Rubin, I Benjamin, K Behbakht, et al.
The American Journal of Clinical Nutrition|March 29, 2013
Gastric cancer in Zambian adults: a prospective case-control study that assessed dietary intake and antioxidant status by using urinary isoprostane excretionAkwi W Asombang, Violet Kayamba, Mpala Mwanza-Lisulo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Impact of raloxifene or tamoxifen use on endometrial cancer risk: a population-based case-control studyAngela DeMichele, Andrea B Troxel, Jesse A Berlin, et al.
Environmental Health Perspectives|June 15, 2000
Workshop to identify critical windows of exposure for children's health: reproductive health in children and adolescents work group summaryG K Lemasters, S D Perreault, B F Hales, et al.
Cancer Biology & Therapy|July 26, 2011
Tissue-based immune monitoring I: tumor core needle biopsies allow in-depth interrogation of the tumor microenvironmentAndrea R Hagemann, Mark Cadungog, Ian S Hagemann, et al.
Gynecologic Oncology|March 31, 2015
A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation - An NRG Oncology/Gynecologic Oncology Group studyRobert L Coleman, Michael W Sill, Katherine Bell-McGuinn, et al.
Pageof 72